Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDS-Testosterone 5% in Adult Male Subjects
NCT01894308Phase 2Not yet recruiting
- Sponsor
- Transdermal Delivery Solutions Corporation
- Start
- Jun 2027
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Testosterone TEPI patch in Hypogonadism, sponsored by Transdermal Delivery Solutions Corporation. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01894308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01894308.